Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wellgistics Health Inc ( (WGRX) ) just unveiled an update.
On October 13, 2025, Wellgistics Health, Inc. announced significant changes in its executive management and board of directors, with Prashant Patel reappointed as President, Interim-CEO, and Board Member. The company also appointed Eric Sherb as Interim-CFO and added Donald Fell, Steven D. Lee, and Howard Doss to the Board. These changes follow the departures of CEO Brian Norton, CFO Mark DiSiena, and COO Tony Madsen, among others. The restructuring aims to streamline operations and capitalize on new revenue opportunities, particularly in the evolving biopharmaceutical supply chain.
More about Wellgistics Health Inc
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The company connects over 6,500 pharmacies and 200 manufacturers, offering services such as wholesale distribution, direct-to-patient delivery, and AI-powered hub services. Wellgistics aims to restore access, transparency, and trust in U.S. healthcare as a PBM-agnostic alternative.
Average Trading Volume: 3,428,661
Technical Sentiment Signal: Strong Sell
Current Market Cap: $46.75M
For an in-depth examination of WGRX stock, go to TipRanks’ Overview page.